Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
01/05/2006 | WO2003087338A3 Her-2 receptor tyrosine kinase molecules and uses thereof |
01/05/2006 | WO2003031598A3 Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use |
01/05/2006 | WO2003016493A3 Transporters and ion channels |
01/05/2006 | US20060005283 Non-dehiscent sesame variety S28 |
01/05/2006 | US20060005282 Production and use of salt tolerant and culture density tolerant organisms |
01/05/2006 | US20060005278 Ethylene insensitive plants |
01/05/2006 | US20060005277 cDNAs encoding polypeptides |
01/05/2006 | US20060005275 Maize metallothionein promoter |
01/05/2006 | US20060005274 Maize metallothionein 2 promoter and methods of use |
01/05/2006 | US20060005273 Novel maize split-seed explant and methods for in vitro regeneration of maize |
01/05/2006 | US20060005267 Peptide deformylase |
01/05/2006 | US20060005265 Ryegrass CBF3 gene: identification and isolation |
01/05/2006 | US20060004186 P. ariasi polypeptides, p. perniciosus polypeptides and methods of use |
01/05/2006 | US20060003996 Intralesional treatment of psoriasis |
01/05/2006 | US20060003958 Novel polynucleotides related to oligonucleotide arrays to monitor gene expression |
01/05/2006 | US20060003952 Oligomeric compounds having modified phosphate groups |
01/05/2006 | US20060003934 Polypeptide; polyethylene glycolylated polypeptide; antidiabetic agents; side effect reduction |
01/05/2006 | US20060003932 Method for promoting neovascularization |
01/05/2006 | US20060003924 Sulfation-independent L-selectin or E-selectin ligand (HCELL) and therapeutics thereof |
01/05/2006 | US20060003920 LAT1 transporters expressed in cancer cells |
01/05/2006 | US20060003453 High-efficiency AAV helper functions |
01/05/2006 | US20060003452 Vector packaging cell line |
01/05/2006 | US20060003451 Cell lines and constructs useful in production of E1-deleted adenoviruses in absence of replication competent adenovirus |
01/05/2006 | US20060003450 introducing a selectable marker that is under the control of a promoter of a gene that is differentially expressed in neural progenitor, culturing in vitro to induce differentiation into neural progenitor cells and selecting for the marker |
01/05/2006 | US20060003449 Plant artificial chromosome compositions and methods |
01/05/2006 | US20060003448 Dry powder cells and cell culture reagents and methods of production thereof |
01/05/2006 | US20060003447 Dry powder cells and cell culture reagents and methods of production thereof |
01/05/2006 | US20060003446 Mesoderm and definitive endoderm cell populations |
01/05/2006 | US20060003445 Method and device for detecting feline immunodeficiency virus |
01/05/2006 | US20060003444 Cells for detection of influenza and parainfluenza viruses |
01/05/2006 | US20060003443 Recombinase-expressing cells |
01/05/2006 | US20060003442 Cell culture scaffold, methods of manufacturing the scaffold and cell culture methods |
01/05/2006 | US20060003441 Method for cultivating cells, particularly human or animal cells |
01/05/2006 | US20060003436 Liver assist device for propagating/culturing hepatocytes; microfluidics; volume of a chamber formed between two plates sandwiching a compressible gasket and an incompressible stop can be adjusted using a gasket that forms a fluid-tight seal betweenplates at a plurality of levels of compression |
01/05/2006 | US20060003430 Lysophosphatidic acit acetyltransferases |
01/05/2006 | US20060003422 Method for the identification of substances mimicking mammal epitopes |
01/05/2006 | US20060003420 Monomeric and dimeric fluorescent protein variants and methods for making same |
01/05/2006 | US20060003419 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
01/05/2006 | US20060003418 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
01/05/2006 | US20060003417 Polypeptide; polyethylene glycolylated polypeptide; antidiabetic agents; side effect reduction |
01/05/2006 | US20060003412 Protein engineering with analogous contact environments |
01/05/2006 | US20060003405 Method of expressing recombinant protein in cho cells |
01/05/2006 | US20060003387 Cell display libraries |
01/05/2006 | US20060003379 Smad6 and uses thereof |
01/05/2006 | US20060003378 Expressed by keratinocytes, wound-healing and chondrosarcoma tissue; nucleic acids comprising polynucleotide of given sequence; use in diagnostics and therapeutics |
01/05/2006 | US20060003358 Polymorphic kinase anchor proteins and nucleic acids encoding the same |
01/05/2006 | US20060003355 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
01/05/2006 | US20060003343 Primer and probe design for efficient amplification and detection of HCV 3' non-translating region |
01/05/2006 | US20060003334 Protein (poly)peptides libraries |
01/05/2006 | US20060003313 For differentiating cells in a cell population comprising pancreatic-duodenal homeobox factor-1 (PDX1) positive (PDX1-expressing) endoderm cells and/or PDX1-negative endoderm cells; cell therapy |
01/05/2006 | US20060003312 Circulating stem cells and uses related thereto |
01/05/2006 | US20060002993 Genetic engineered protein; transgenic animal, used to elicit a humoral or cellular immune response |
01/05/2006 | US20060002952 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs |
01/05/2006 | US20060002945 Non-sensitive antigenic peptide derived from fc portion of the epsilon heavy chain of immunoglobulin-E for use in treatment and prevention of allergic disorders |
01/05/2006 | US20060002927 Use of anti-cd1 antibodies for the modulation of immune responses |
01/05/2006 | US20060002926 isolated and/or recombinant; characterized by high affinity binding of one or more chemokines, such as eotaxin, RANTES and/or MCP-3, and/or the ability to stimulate a (one or more) cellular response(s) (e.g., chemotaxis, exocytosis, release of one or more inflammatory mediators) |
01/05/2006 | US20060002923 Recombinant anti-osteopontin antibody and use thereof |
01/05/2006 | US20060002919 15625 receptor, a novel G-protein coupled receptor |
01/05/2006 | US20060002906 Tolerizing allografts of pluripotent stem cells |
01/05/2006 | US20060002904 Receptor and related products and methods |
01/05/2006 | US20060002901 Composition containing eosinophil cationic protein |
01/05/2006 | US20060002900 Retinal pigment epithelial cell cultures on amniotic membrane and transplantation |
01/05/2006 | US20060002899 Generation of dendritic cells from cd34+precursors |
01/05/2006 | US20060002898 Methods and compositions for correction of cardiac conduction disturbances |
01/05/2006 | US20060002897 Plasmid for tissue targeted treatment of tumors; antitumor agents |
01/05/2006 | US20060002892 Lectin-like transcript (LLTI); Natural killer cells; antitumor agents; quantitative analysis; human lectin transcription factor |
01/05/2006 | DE102004037184B9 Gewebetransplantatkonstrukt zur Rekonstruktion eines menschlichen oder tierischen Organs Tissue transplant construct for reconstructing a human or animal body |
01/05/2006 | DE102004029763A1 Pflanzen, die Amylopektin-Stärke mit neuen Eigenschaften herstellen Plants which produce amylopectin starch with new properties |
01/05/2006 | CA2571849A1 Anticancer agent containing dendritic cell having rna virus transferred thereinto |
01/05/2006 | CA2571844A1 Anticancer agent containing minus-strand rna virus |
01/05/2006 | CA2571611A1 Cell-based therapies for ischemia |
01/05/2006 | CA2571315A1 Ccr ligands for stem cell homing |
01/05/2006 | CA2569031A1 Methods and compositions for producing germ cells from bone marrow derived germline stem cells |
01/05/2006 | CA2568661A1 Human monoclonal antibodies to fc gamma receptor i (cd64) |
01/04/2006 | EP1612271A2 Multiply-substituted protease variants with altered net charge for use in detergents |
01/04/2006 | EP1612268A1 Receptor ligand VEGF-C |
01/04/2006 | EP1612265A2 Bioengineered tissue constructs and methods for producing and using them |
01/04/2006 | EP1612264A1 Organ-forming method |
01/04/2006 | EP1612263A1 PTH receptor and screening assay utilizing the same |
01/04/2006 | EP1612223A2 Polypeptides with FC binding ability |
01/04/2006 | EP1612222A2 Olfactory and pheromones G-protein coupled receptors |
01/04/2006 | EP1612221A2 Receptor-based interaction trap |
01/04/2006 | EP1611233A2 Stem cells having increased sensitivity to sdf-1 and methods of generating and using same |
01/04/2006 | EP1610833A2 Materials and methods for augmenting and/or repairing intervertebral discs |
01/04/2006 | EP1610809A2 Vault and vault-like carrier molecules |
01/04/2006 | EP1490005A4 Methods and devices for selective disruption of fatty tissue by controlled cooling |
01/04/2006 | EP1402076A4 Compositions and methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays |
01/04/2006 | EP1313851B1 Methods and reagents for molecular cloning |
01/04/2006 | EP1311677B1 Regulation of human p2y1-like g protein-coupled receptor |
01/04/2006 | EP1307573B1 Adenoviral vectors for the transduction of chondrocytes |
01/04/2006 | EP1303586B1 Dna/rna-embedding medium and method of use |
01/04/2006 | EP1278867B1 Hcv ns2/3 fragments and uses thereof |
01/04/2006 | EP1202744B1 PRODUCTION OF rhPBGD |
01/04/2006 | EP1169642B1 Complex formed by n-linked glycoproteins (siblings) and factor h |
01/04/2006 | EP1019518B1 Self-deleting vectors for cancer therapy |
01/04/2006 | EP1005542B1 APOLIPOPROTEIN E TRANSGENIC mice AND ASSAY METHODS |
01/04/2006 | EP0992189B1 Animals carrying 25-hydroxylated vitamin d3-24-hydroxylase gene transferred thereinto |
01/04/2006 | EP0954596B1 Enhanced production of taxanes by cell cultures of taxus species |
01/04/2006 | EP0923606B1 Antigenic fusionprotein carrying galalpha1,3gal epitopes |
01/04/2006 | EP0804609B1 NOVEL p53 RESPONSE GENES |